454 related articles for article (PubMed ID: 12197624)
21. Postmenopausal osteoporosis and hormone replacement therapy.
Gambacciani M; Vacca F
Minerva Med; 2004 Dec; 95(6):507-20. PubMed ID: 15785435
[TBL] [Abstract][Full Text] [Related]
22. Dry eye in post-menopausal women using hormone replacement therapy.
Erdem U; Ozdegirmenci O; Sobaci E; Sobaci G; Göktolga U; Dagli S
Maturitas; 2007 Mar; 56(3):257-62. PubMed ID: 17030104
[TBL] [Abstract][Full Text] [Related]
23. Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women.
Gambacciani M; Cappagli B; Ciaponi M; Pepe A; Vacca F; Genazzani AR
Maturitas; 2008 Jan; 59(1):2-6. PubMed ID: 18063490
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Pueraria lobata with hormone replacement therapy in treating the adverse health consequences of menopause.
Woo J; Lau E; Ho SC; Cheng F; Chan C; Chan AS; Haines CJ; Chan TY; Li M; Sham A
Menopause; 2003; 10(4):352-61. PubMed ID: 12851519
[TBL] [Abstract][Full Text] [Related]
25. The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women.
Alexandersen P; Tankó LB; Bagger YZ; Qin G; Christiansen C
Climacteric; 2006 Apr; 9(2):108-18. PubMed ID: 16698657
[TBL] [Abstract][Full Text] [Related]
26. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the relative rates of bone mineral content loss in postmenopause due to both estrogen deficiency and ageing.
Gnudi S; Mongiorgi R; Figus E; Bertocchi G
Boll Soc Ital Biol Sper; 1990 Dec; 66(12):1153-9. PubMed ID: 2100526
[TBL] [Abstract][Full Text] [Related]
28. Menopausal symptoms and knowledge towards daily life and hormone replacement therapy among menopausal women in Bangkok.
Chaopotong P; Titapant V; Boriboonhirunsarn D
J Med Assoc Thai; 2005 Dec; 88(12):1768-74. PubMed ID: 16518972
[TBL] [Abstract][Full Text] [Related]
29. Prevention of postmenopausal bone loss with long-cycle hormone replacement therapy.
Popp AW; Bodmer C; Senn C; Fuchs G; Kraenzlin ME; Wyss H; Birkhaeuser MH; Lippuner K
Maturitas; 2006 Jan; 53(2):191-200. PubMed ID: 16368472
[TBL] [Abstract][Full Text] [Related]
30. Effects of exercise training on bone remodeling, insulin-like growth factors, and bone mineral density in postmenopausal women with and without hormone replacement therapy.
Milliken LA; Going SB; Houtkooper LB; Flint-Wagner HG; Figueroa A; Metcalfe LL; Blew RM; Sharp SC; Lohman TG
Calcif Tissue Int; 2003 Apr; 72(4):478-84. PubMed ID: 12574871
[TBL] [Abstract][Full Text] [Related]
31. Effects of mild asymptomatic primary hyperparathyroidism on bone mass in women with and without estrogen replacement therapy.
McDermott MT; Perloff JJ; Kidd GS
J Bone Miner Res; 1994 Apr; 9(4):509-14. PubMed ID: 8030438
[TBL] [Abstract][Full Text] [Related]
32. Physician counseling on hormone replacement therapy and bone loss: do socioeconomic and racial characteristics of women influence counseling?
Neuner JM; McCarthy EP; Davis RB; Phillips RS
J Womens Health (Larchmt); 2003 Jun; 12(5):495-504. PubMed ID: 12869297
[TBL] [Abstract][Full Text] [Related]
33. Effect of hormonal replacement therapy on skin biophysical properties of menopausal women.
Guinot C; Malvy D; Ambroisine L; Latreille J; Mauger E; Guéhenneux S; Morizot F; Tschachler E
Skin Res Technol; 2005 Aug; 11(3):201-4. PubMed ID: 15998332
[TBL] [Abstract][Full Text] [Related]
34. Surgical versus natural menopause: cognitive issues.
Henderson VW; Sherwin BB
Menopause; 2007; 14(3 Pt 2):572-9. PubMed ID: 17476147
[TBL] [Abstract][Full Text] [Related]
35. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD
Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757
[TBL] [Abstract][Full Text] [Related]
36. Assessment of DNA damage in postmenopausal women under hormone replacement therapy.
Ozcagli E; Sardas S; Biri A
Maturitas; 2005 Jul; 51(3):280-5. PubMed ID: 15978971
[TBL] [Abstract][Full Text] [Related]
37. Long-term postmenopausal hormone replacement therapy effects on bone mass: differences between surgical and spontaneous patients.
Castelo-Branco C; Figueras F; Sanjuan A; Pons F; Vicente JJ; Vanrell JA
Eur J Obstet Gynecol Reprod Biol; 1999 Apr; 83(2):207-11. PubMed ID: 10391534
[TBL] [Abstract][Full Text] [Related]
38. [Comparison of the effect of fluoxetine combined with hormone replacement therapy (HRT) and single HRT in treating menopausal depression].
Yu Q; Yin CX; Hui Y; Yu J; He FF; Wei J; Wu YY
Zhonghua Fu Chan Ke Za Zhi; 2004 Jul; 39(7):461-4. PubMed ID: 15347469
[TBL] [Abstract][Full Text] [Related]
39. The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women.
Arrenbrecht S; Caubel P; Garnero P; Felsenberg D
Maturitas; 2004 Jul; 48(3):197-207. PubMed ID: 15207885
[TBL] [Abstract][Full Text] [Related]
40. Effect of hormone replacement therapy on hemostatic variables in post-menopausal women.
Al-Farra HM; Al-Fahoum SK; Tabbaa MA
Saudi Med J; 2005 Dec; 26(12):1930-5. PubMed ID: 16380775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
